Cargando…

Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration

AIMS: To investigate the natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration. METHODS: We collected data of patients with PKAN by searching from available publications in English and Chinese. Patients diagnosed in our center (Peking University First...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xuting, Zhang, Jie, Jiang, Yuwu, Wang, Jingmin, Wu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298993/
https://www.ncbi.nlm.nih.gov/pubmed/32043823
http://dx.doi.org/10.1111/cns.13294
_version_ 1783547313894981632
author Chang, Xuting
Zhang, Jie
Jiang, Yuwu
Wang, Jingmin
Wu, Ye
author_facet Chang, Xuting
Zhang, Jie
Jiang, Yuwu
Wang, Jingmin
Wu, Ye
author_sort Chang, Xuting
collection PubMed
description AIMS: To investigate the natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration. METHODS: We collected data of patients with PKAN by searching from available publications in English and Chinese. Patients diagnosed in our center (Peking University First Hospital) were also included. The difference in natural history and genotype between early‐onset (<10 year of age at onset) and late‐onset patients (≥10 year of age at onset) with PKAN was compared. RESULTS: A total of 248 patients were included. The median age at onset was 3.0 years in the early‐onset group and 18.0 years in the late‐onset group. Dystonia in lower limbs was the most common initial symptom in both groups. In the early‐onset group, the median interval between the disease onset and occurrence of oromandibular dystonia, generalized dystonia, loss of independent ambulance was 6.0 years, 5.0 years, and 5.0 years. The corresponding values in late‐onset group were 1.0 year, 4.0 years, and 6.0 years. About 20.0% died at median age of 12.5 years and 9.5 years after the onset in early‐onset group. About 2.0% of the late‐onset patients died during the follow‐up. A total of 176 mutations were identified. Patients carrying two null alleles in PANK2 showed significantly earlier age of disease onset and progressed more rapidly to loss of independent ambulance. CONCLUSIONS: This study provided a comprehensive review on the natural history and genotype of 248 patients with PKAN. The results will serve as a historical control data for future clinical trial on PKAN.
format Online
Article
Text
id pubmed-7298993
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72989932020-06-18 Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration Chang, Xuting Zhang, Jie Jiang, Yuwu Wang, Jingmin Wu, Ye CNS Neurosci Ther Original Articles AIMS: To investigate the natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration. METHODS: We collected data of patients with PKAN by searching from available publications in English and Chinese. Patients diagnosed in our center (Peking University First Hospital) were also included. The difference in natural history and genotype between early‐onset (<10 year of age at onset) and late‐onset patients (≥10 year of age at onset) with PKAN was compared. RESULTS: A total of 248 patients were included. The median age at onset was 3.0 years in the early‐onset group and 18.0 years in the late‐onset group. Dystonia in lower limbs was the most common initial symptom in both groups. In the early‐onset group, the median interval between the disease onset and occurrence of oromandibular dystonia, generalized dystonia, loss of independent ambulance was 6.0 years, 5.0 years, and 5.0 years. The corresponding values in late‐onset group were 1.0 year, 4.0 years, and 6.0 years. About 20.0% died at median age of 12.5 years and 9.5 years after the onset in early‐onset group. About 2.0% of the late‐onset patients died during the follow‐up. A total of 176 mutations were identified. Patients carrying two null alleles in PANK2 showed significantly earlier age of disease onset and progressed more rapidly to loss of independent ambulance. CONCLUSIONS: This study provided a comprehensive review on the natural history and genotype of 248 patients with PKAN. The results will serve as a historical control data for future clinical trial on PKAN. John Wiley and Sons Inc. 2020-02-11 /pmc/articles/PMC7298993/ /pubmed/32043823 http://dx.doi.org/10.1111/cns.13294 Text en © 2020 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Chang, Xuting
Zhang, Jie
Jiang, Yuwu
Wang, Jingmin
Wu, Ye
Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title_full Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title_fullStr Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title_full_unstemmed Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title_short Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
title_sort natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298993/
https://www.ncbi.nlm.nih.gov/pubmed/32043823
http://dx.doi.org/10.1111/cns.13294
work_keys_str_mv AT changxuting naturalhistoryandgenotypephenotypecorrelationofpantothenatekinaseassociatedneurodegeneration
AT zhangjie naturalhistoryandgenotypephenotypecorrelationofpantothenatekinaseassociatedneurodegeneration
AT jiangyuwu naturalhistoryandgenotypephenotypecorrelationofpantothenatekinaseassociatedneurodegeneration
AT wangjingmin naturalhistoryandgenotypephenotypecorrelationofpantothenatekinaseassociatedneurodegeneration
AT wuye naturalhistoryandgenotypephenotypecorrelationofpantothenatekinaseassociatedneurodegeneration